Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Hyun-Jung Byun"'
Publikováno v:
Biomolecules & Therapeutics. 31:330-339
Publikováno v:
Pharmaceuticals, Vol 14, Iss 12, p 1247 (2021)
EphB3 is a major key player in a variety of cellular activities, including cell migration, proliferation, and apoptosis. However, the exact role of EphB3 in cancer remains ambiguous. Accordingly, new EphB3 inhibitors can increase the understanding of
Externí odkaz:
https://doaj.org/article/e4331e5147764b329ce2450f225ac392
Autor:
Hyun Ji Kim, Mi Kyung Park, Hyun Jung Byun, Minkyoung Kim, Boram Kim, Lu Yu, Tuan Minh Nguyen, Thi Ha Nguyen, Phuong Anh Do, Eun Ji Kim, Ji Hyun Kim, Enkhmend Enkhtaivan, Kyung Sung Kim, Ji Yun Jang, Gyeoung Jin Kang, Ho Lee, Misun Won, Kyeong Lee, Jungsook Cho, Chang Hoon Lee
Publikováno v:
Antioxidants, Vol 10, Iss 11, p 1674 (2021)
LW1497 suppresses the expression of the hypoxia-inducing factor (HIF)-1α inhibiting malate dehydrogenase. Although hypoxia and HIF-1α are known to be important in cancer, LW1497 has not been therapeutically applied to cancer yet. Thus, we investiga
Externí odkaz:
https://doaj.org/article/141c8b24db014edda9b8f8ddc25a88ea
Publikováno v:
Biomolecules & Therapeutics
Metformin is an anti-diabetic drug and has anticancer effects on various cancers. Several studies have suggested that metformin reduces cell proliferation and stimulates cell-cycle arrest and apoptosis. However, the definitive molecular mechanism of
Publikováno v:
Biomolecules & Therapeutics
The imprinted tumour suppressor NOEY2 is downregulated in various cancer types, including ovarian cancers. Recent data suggest that NOEY2 plays an essential role in regulating the cell cycle, angiogenesis and autophagy in tumorigenesis. However, its
Autor:
Gyeoung Jin Kang, Jung Ho Park, Hyun Ji Kim, Eun Ji Kim, Boram Kim, Hyun Jung Byun, Lu Yu, Tuan Minh Nguyen, Thi Ha Nguyen, Kyung Sung Kim, Hiệu Phùng Huy, Mostafizur Rahman, Ye Hyeon Kim, Ji Yun Jang, Mi Kyung Park, Ho Lee, Chang Ick Choi, Kyeong Lee, Hyo Kyung Han, Jungsook Cho, Seung Bae Rho, Chang Hoon Lee
Publikováno v:
Biomoleculestherapeutics. 30(4)
Advanced or metastatic breast cancer affects multiple organs and is a leading cause of cancer-related death. Cancer metastasis is associated with epithelial-mesenchymal metastasis (EMT). However, the specific signals that induce and regulate EMT in c
Autor:
Kyeong Lee, Tuan Minh Nguyen, Hyun Ji Kim, Boram Kim, Minkyoung Kim, Enkhmend Enkhtaivan, Kyung Sung Kim, Ji Yun Jang, Eun Ji Kim, Thi Ha Nguyen, Hyun Jung Byun, Chang-Hoon Lee, Ho Lee, Phuong Anh Do, Jungsook Cho, Lu Yu, Misun Won, Gyeoung Jin Kang, Ji Hyun Kim, Mi Kyung Park
Publikováno v:
Antioxidants, Vol 10, Iss 1674, p 1674 (2021)
Antioxidants
Volume 10
Issue 11
Antioxidants
Volume 10
Issue 11
LW1497 suppresses the expression of the hypoxia-inducing factor (HIF)-1α inhibiting malate dehydrogenase. Although hypoxia and HIF-1α are known to be important in cancer, LW1497 has not been therapeutically applied to cancer yet. Thus, we investiga
Publikováno v:
Oncotarget
// Hyun Ji Kim 1 , Hyun Jung Byun 1 , Mi Kyung Park 1 , Eun Ji Kim 1 , Gyeoung Jin Kang 1 , Chang Hoon Lee 1 1 College of Pharmacy, Dongguk University, Seoul 100-715, Republic of Korea Correspondence to: Chang Hoon Lee, email: uatheone@dongguk.edu Ke
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 7622, p 7622 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 20
International Journal of Molecular Sciences
Volume 21
Issue 20
HPV16 E6 oncoprotein is a member of the human papillomavirus (HPV) family that contributes to enhanced cellular proliferation and risk of cervical cancer progression via viral infection. In this study, interferon regulatory factor-1 (IRF-1) regulates
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1247, p 1247 (2021)
Pharmaceuticals
Pharmaceuticals; Volume 14; Issue 12; Pages: 1247
Pharmaceuticals
Pharmaceuticals; Volume 14; Issue 12; Pages: 1247
EphB3 is a major key player in a variety of cellular activities, including cell migration, proliferation, and apoptosis. However, the exact role of EphB3 in cancer remains ambiguous. Accordingly, new EphB3 inhibitors can increase the understanding of